{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:10:40Z","timestamp":1791403840234,"version":"4.3.3"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2 and 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>Recent studies have shown that mild traumatic brain injury (mTBI) is associated with higher risk for anxiety-related disorders. Dysregulation in the hypothalamus\u2013pituitary\u2013adrenal (HPA) axis following mTBI has been proposed to be involved in the development of neurobehavioral abnormalities; however, the underlying mechanisms are largely unknown. The aim of this study was to determine whether the corticotropin-releasing-factor-1 (CRF-1) receptor is involved in the regulation of anxiety-related symptoms in a mouse model of mTBI. Animals with or without mTBI received intracerebroventricular injections of a CRF-1 receptor agonist (CRF; 0.01\u2009nmol\/mouse) or antagonist (antalarmin; 1\u2009\u00b5g\/mouse) for 5 days, and then the animals were subjected to anxiety tests (light-dark box and zero maze). The levels of adrenocorticotropic hormone and corticosterone, the most important markers of HPA axis, were also measured after behavioral tests. Our results indicated that mTBI-induced anxiety-related symptoms in mice through increased levels of adrenocorticotropic hormone and corticosterone, showing HPA axis hyperactivity. Interestingly, activation of CRF receptor by a subthreshold dose of CRF resulted in significant increases in anxiety-like behaviors and HPA axis response to stress, whereas blockade of CRF receptors by a subthreshold dose of antalarmin decreased anxiety-related symptoms and HPA axis response to stress in mTBI-induced mice. Collectively, these findings suggest that the CRF-1 receptor plays an important role in the regulation of anxiety-related behaviors following mTBI induction in mice and support the hypothesis that blockade of the CRF-1 receptor may be a promising therapeutic target for anxiety-related disorders in patients with TBI.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000450","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T02:16:21Z","timestamp":1541211381000},"page":"220-228","source":"Crossref","is-referenced-by-count":24,"title":["The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus\u2013pituitary\u2013adrenal axis reactivity in mice with mild traumatic brain injury"],"prefix":"10.1097","volume":"30","author":[{"given":"Morteza","family":"Kosari-Nasab","sequence":"first","affiliation":[{"name":"Drug Applied Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayebeh","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Department of Biology, Kerman Branch, Islamic Azad University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Bashiri","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaffar","family":"Shokouhi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"},{"name":"Neuroscience Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Akbar","family":"Salari","sequence":"additional","affiliation":[{"name":"Drug Applied Research Center"},{"name":"Salari Institute of Cognitive and Behavioral Disorders (SICBD), Alborz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/da.20220","article-title":"HPA axis activity in patients with panic disorder: review and synthesis of four studies","volume":"24","author":"Abelson","year":"2007","journal-title":"Depress Anxiety"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2265.2004.02023.x","article-title":"Neuroendocrine dysfunction in the acute phase of traumatic brain injury","volume":"60","author":"Agha","year":"2004","journal-title":"Clin Endocrinol"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2013.04.056","article-title":"Neonatal NMDA receptor blockade alters anxiety-and depression-related behaviors in a sex-dependent manner in mice","volume":"73","author":"Amani","year":"2013","journal-title":"Neuropharmacology"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/01616412.2017.1376789","article-title":"TAMEC: a new analogue of cyclomyrsinol diterpenes decreases anxiety-and depression-like behaviors in a mouse model of multiple sclerosis","volume":"39","author":"Ayatollahi","year":"2017","journal-title":"Neurol Res"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1099800408326453","article-title":"Functional status, chronic stress, and cortisol response after mild-to-moderate traumatic brain injury","volume":"10","author":"Bay","year":"2009","journal-title":"Biol Res Nurs"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/cen.13562","article-title":"Cortisol evaluation during the acute phase of traumatic brain injury \u2013 a prospective study","volume":"88","author":"Bensalah","year":"2018","journal-title":"Clin Endocrinol"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.pnpbp.2010.04.025","article-title":"Reversal by quercetin of corticotrophin releasing factor induced anxiety-and depression-like effect in mice","volume":"34","author":"Bhutada","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000126377","article-title":"Role of endogenous corticotropin releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats","volume":"57","author":"B\u00edr\u00f3","year":"1993","journal-title":"Neuroendocrinology"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02699052.2017.1380228","article-title":"Repeated mild traumatic brain injury produces neuroinflammation, anxiety-like behaviour and impaired spatial memory in mice","volume":"32","author":"Broussard","year":"2018","journal-title":"Brain Inj"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/026990599121016","article-title":"Neuroendocrine responses following graded traumatic brain injury in male adults","volume":"13","author":"Cernak","year":"1999","journal-title":"Brain Inj"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/00005373-198809000-00011","article-title":"Plasma pituitary hormone levels in severe trauma with or without head injury","volume":"28","author":"Chiolero","year":"1988","journal-title":"J Trauma"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1097\/01.CCM.0000181735.51183.A7","article-title":"Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study","volume":"33","author":"Cohan","year":"2005","journal-title":"Crit Care Med"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/74255","article-title":"Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2","volume":"24","author":"Coste","year":"2000","journal-title":"Nat Genet"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/00003246-199808000-00030","article-title":"Provocative hypothalamopituitary axis tests in severe head injury: correlations with severity and prognosis","volume":"26","author":"Della Corte","year":"1998","journal-title":"Crit Care Med"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2014.09.002","article-title":"Alterations in HPA-axis and autonomic nervous system functioning in childhood anxiety disorders point to a chronic stress hypothesis","volume":"51","author":"Dieleman","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00134-005-2689-y","article-title":"Hypothalamic\u2013pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury","volume":"31","author":"Dimopoulou","year":"2005","journal-title":"Intensive Care Med"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00134-004-2257-x","article-title":"Endocrine abnormalities in critical care patients with moderate-to-severe head trauma: incidence, pattern and predisposing factors","volume":"30","author":"Dimopoulou","year":"2004a","journal-title":"Intensive Care Med"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.CCM.0000108885.37811.CA","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels","volume":"32","author":"Dimopoulou","year":"2004b","journal-title":"Crit Care Med"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.brainresbull.2011.08.015","article-title":"Maternal infection during late pregnancy increases anxiety-and depression-like behaviors with increasing age in male offspring","volume":"87","author":"Enayati","year":"2012","journal-title":"Brain Res Bull"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/jcem-57-6-1245","article-title":"Loss of adrenocortical suppression after acute brain injury: role of increased intracranial pressure and brain stem function","volume":"57","author":"Feibel","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuroscience.2011.01.028","article-title":"Heightening of the stress response during the first weeks after a mild traumatic brain injury","volume":"178","author":"Griesbach","year":"2011","journal-title":"Neuroscience"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1089\/neu.2011.2229","article-title":"Differential effects of voluntary and forced exercise on stress responses after traumatic brain injury","volume":"29","author":"Griesbach","year":"2012","journal-title":"J Neurotrauma"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1089\/08977150152725669","article-title":"The hypothalamo\u2013pituitary\u2013adrenal axis response to experimental traumatic brain injury","volume":"18","author":"Grundy","year":"2001","journal-title":"J Neurotrauma"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1073\/pnas.97.11.6079","article-title":"Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates","volume":"97","author":"Habib","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01708405","article-title":"Endocrine abnormalities in severe traumatic brain injury \u2013 a cue to prognosis in severe craniocerebral trauma?","volume":"17","author":"Hackl","year":"1991","journal-title":"Intensive Care Med"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(92)90708-H","article-title":"Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action","volume":"581","author":"Heinrichs","year":"1992","journal-title":"Brain Res"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.npp.1380104","article-title":"Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity","volume":"11","author":"Heinrichs","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo\u2013pituitary\u2013adrenocortical responsiveness","volume":"24","author":"Herman","year":"2003","journal-title":"Front Neuroendocrinol"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00000542-200210000-00010","article-title":"Cortisol response to corticotropin stimulation in trauma patients influence of hemorrhagic shock","volume":"97","author":"Hoen","year":"2002","journal-title":"Anesthesiology"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","article-title":"Central CRH system in depression and anxiety \u2013 evidence from clinical studies with CRH1 receptor antagonists","volume":"583","author":"Holsboer","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1037\/neu0000037","article-title":"The neuropsychological outcomes of concussion: a systematic review of meta-analyses on the cognitive sequelae of mild traumatic brain injury","volume":"28","author":"Karr","year":"2014","journal-title":"Neuropsychology"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1097\/00001756-199711100-00044","article-title":"\u03b1\u2010Helical CRF9\u201041 prevents anxiogenic\u2010like effect of NPY Y1 receptor antagonist BIBP3226 in rats","volume":"8","author":"Kask","year":"1997","journal-title":"Neuroreport"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.0953-816X.2000.01383.x","article-title":"The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats","volume":"13","author":"Keck","year":"2001","journal-title":"Eur J Neurosci"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0404.1997.tb00238.x","article-title":"Changes of sympatho\u2010adrenal and hypothalamo\u2013pituitary\u2013adrenocortical system in patients with head injury","volume":"96","author":"Koiv","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2017.11.012","article-title":"Anxiolytic-and antidepressant-like effects of silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury","volume":"338","author":"Kosari-Nasab","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.10.009","article-title":"Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety-and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice","volume":"120","author":"Majidi","year":"2016","journal-title":"Brain Res Bull"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0022-3565(25)38740-9","article-title":"Characterization of a novel and potent corticotropin-releasing factor antagonist in rats","volume":"269","author":"Menzaghi","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R38-20230910","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/neu.2005.369ER","article-title":"Abnormalities of pituitary function after traumatic brain injury in children","volume":"24","author":"Niederland","year":"2007","journal-title":"J Neurotrauma"},{"key":"R39-20230910","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/neu0000221","article-title":"Prevalence of anxiety following adult traumatic brain injury: a meta-analysis comparing measures, samples and postinjury intervals","volume":"30","author":"Osborn","year":"2016","journal-title":"Neuropsychology"},{"key":"R40-20230910","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yhbeh.2014.01.003","article-title":"Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level","volume":"65","author":"Patricia","year":"2014","journal-title":"Horm Behav"},{"key":"R43-20230910","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1460-9568.1998.00064.x","article-title":"Evidence for the involvement of corticotrophin\u2010releasing hormone in the pathogenesis of traumatic brain injury","volume":"10","author":"Roe","year":"1998","journal-title":"Eur J Neurosci"},{"key":"R44-20230910","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrneurol.2013.22","article-title":"Changing patterns in the epidemiology of traumatic brain injury","volume":"9","author":"Roozenbeek","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R45-20230910","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.euroneuro.2015.04.022","article-title":"Activation of GABA-A receptors during postnatal brain development increases anxiety-and depression-related behaviors in a time-and dose-dependent manner in adult mice","volume":"25","author":"Salari","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"R46-20230910","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/neu.2013.3177","article-title":"Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury","volume":"31","author":"Santarsieri","year":"2014","journal-title":"J Neurotrauma"},{"key":"R47-20230910","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2011.07.027","article-title":"Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment","volume":"62","author":"Sartori","year":"2012","journal-title":"Neuropharmacology"},{"key":"R48-20230910","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00134-004-2306-5","article-title":"Cortisol dynamics following acute severe brain injury","volume":"30","author":"Savaridas","year":"2004","journal-title":"Intensive Care Med"},{"key":"R49-20230910","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1089\/neu.2015.4252","article-title":"Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury: a systematic review","volume":"33","author":"Scholten","year":"2016","journal-title":"J Neurotrauma"},{"key":"R50-20230910","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0893-133X(99)00108-6","article-title":"Behavioral effects of central administration of the novel CRF antagonist astressin in rats","volume":"22","author":"Spina","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"R51-20230910","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1227\/00006123-197911000-00003","article-title":"Serum cortisol abnormalities after craniocerebral trauma","volume":"5","author":"Steinbok","year":"1979","journal-title":"Neurosurgery"},{"key":"R52-20230910","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1523\/JNEUROSCI.14-05-02579.1994","article-title":"Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior","volume":"14","author":"Stenzel-Poore","year":"1994","journal-title":"J Neurosci"},{"key":"R53-20230910","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/jc.2005-2476","article-title":"High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma","volume":"91","author":"Tanriverdi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-20230910","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1089\/neu.2006.23.1802","article-title":"Lasting neuroendocrine-immune effects of traumatic brain injury in rats","volume":"23","author":"Taylor","year":"2006","journal-title":"J Neurotrauma"},{"key":"R55-20230910","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/neu.2007.0486","article-title":"Injury severity differentially affects short-and long-term neuroendocrine outcomes of traumatic brain injury","volume":"25","author":"Taylor","year":"2008","journal-title":"J Neurotrauma"},{"key":"R56-20230910","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/neu.2017.5238","article-title":"Sex differences in thermal, stress, and inflammatory responses to minocycline administration in rats with traumatic brain injury","volume":"35","author":"Taylor","year":"2018","journal-title":"J Neurotrauma"},{"key":"R57-20230910","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2011.09.004","article-title":"The CRH-R1 receptor mediates luteinizing hormone, prolactin, corticosterone and progesterone secretion induced by restraint stress in estrogen-primed rats","volume":"1421","author":"Traslavi\u00f1a","year":"2011","journal-title":"Brain Res"},{"key":"R58-20230910","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/neu.2010.1586","article-title":"Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury","volume":"28","author":"Wagner","year":"2011","journal-title":"J Neurotrauma"},{"key":"R59-20230910","first-page":"1252","article-title":"Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation","volume":"29","author":"Webster","year":"2002","journal-title":"J Rheumatol"},{"key":"R60-20230910","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1530-0277.1990.tb01838.x","article-title":"The adrenocortical response to brain injury: correlation with the severity of neurologic dysfunction, effects of intoxication, and patient outcome","volume":"14","author":"Woolf","year":"1990","journal-title":"Alcohol Clin Exp Res"},{"key":"R61-20230910","first-page":"209","article-title":"Neuroendocrine abnormalities in patients with traumatic brain injury","volume":"12","author":"Yuan","year":"1991","journal-title":"Front Neuroendocrinol"},{"key":"R62-20230910","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-8993(02)03189-X","article-title":"Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat","volume":"952","author":"Zorrilla","year":"2002","journal-title":"Brain Res"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201904000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:19:32Z","timestamp":1775258372000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201904000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":60,"journal-issue":{"issue":"2 and 3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000450","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}